8 Results for "

estrogen-dependent diseases

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "estrogen-dependent diseases" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-14247B
CAS No.: 176702-70-8
Synonyms: CGS 16949A hemihydrate; (Rac)-FAD286 hydrochloride hemihydrate
Target:  

Cytochrome P450

Research Areas:  

Endocrinology Cancer

Fadrozole hydrochloride hemihydrate is an orally active, potent, selective and nonsteroidal aromatase inhibitor, with an IC50 of 6.4 nM. Fadrozole hydrochloride hemihydrate inhibits the production of estrogen and progesterone, with IC50 values of 0.03 and 120 μM. Fadrozole hydrochloride hemihydrate shows prevention of spontaneous tumours. Fadrozole hydrochloride hemihydrate can be used for the research of estrogen-dependent disease and cancer .
loading...
    loading...
Cat. No.: HY-164764
CAS No.: 1067189-44-9
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology

ADX61623 is a potent follicle stimulating hormone (FSH) receptor (FSHR) negative allosteric modulator (NAM). ADX61623 shows luteinizing hormone receptor (LH-R) activity and is not active on thyroid-stimulating hormone (TSH) receptors. ADX61623 can be used for the study of estrogen dependent disease .
loading...
    loading...
Cat. No.: HY-W002734
CAS No.: 87199-18-6
Synonyms: 3-Hydroxybenzeneboronic acid
Target:  

Drug Intermediate

Research Areas:  

Metabolic Disease

(3-Hydroxyphenyl)boronic acid (3-Hydroxybenzeneboronic acid) is a drug intermediate that can be used for the synthesis of 17β-hydroxysteroid dehydrogenase type 1 inhibitors .
loading...
    loading...
Cat. No.: HY-151201
CAS No.: 2990549-76-1
Target:  

Steroid Sulfatase

Research Areas:  

Cancer

Steroid sulfatase/17β-HSD1-IN-3 (compound 19) is a dual inhibitor of steroid sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1 (17β HSD1). Steroid sulfatase/17β-HSD1-IN-3 irreversibly inhibits hSTS activity with anIC50 value of 27 nM. Steroid sulfatase/17β-HSD1-IN-3 can be used in the study of endometriosis and other estrogen-dependent diseases .
loading...
    loading...
Cat. No.: HY-151202
CAS No.: 2990549-94-3
Target:  

Steroid Sulfatase

Research Areas:  

Cancer

Steroid sulfatase/17β-HSD1-IN-4 (compound 37) is a dual inhibitor of steroid sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1 (17β HSD1). Steroid sulfatase/17β-HSD1-IN-4 irreversibly inhibits hSTS activity with anIC50 value of 63 nM. Steroid sulfatase/17β-HSD1-IN-4 can be used in the study of endometriosis and other estrogen-dependent diseases .
loading...
    loading...
Cat. No.: HY-173279
CAS No.: 889959-22-2
Target:  

Cytochrome P450

Research Areas:  

Endocrinology

CYP19A1-IN-1 (Compound 9) is a CYP19A1 inhibitor with an IC50 of 271 nM. CYP19A1-IN-1 inhibits the activity of converting androgens to estrogens by binding to CYP19A1. CYP19A1-IN-1 can be used in the research of sex hormone-related diseases such as estrogen-dependent breast cancer .
loading...
    loading...
Cat. No.: HY-151199
CAS No.: 2990549-70-5
Target:  

Steroid Sulfatase

Research Areas:  

Endocrinology Cancer

Steroid sulfatase/17β-HSD1-IN-1 is a potent steroid sulfatase and 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitor with an IC50 value of 28 nM for cellular human steroid sulfatase. Steroid sulfatase/17β-HSD1-IN-1 can be used to research estrogen-dependent diseases .
loading...
    loading...
Cat. No.: HY-187622
CAS No.: 148714-92-5
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease Cancer

Org 33201 is an orally active and selective Aromatase inhibitor with an IC50 of 2.2 nM. Org 33201 inhibits the activity of Aromatase by binding to its heme iron. Org 33201 can be used in the study of estrogen-dependent diseases (such as postmenopausal breast cancer) .
loading...
    loading...